Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a beauty supplement make hair thicker? new study investigates

NCT ID NCT07520019

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This 3-month study tests two doses of a dietary supplement containing biotin, collagen, keratin, and hyaluronic acid in 40 adults aged 21-50 with self-perceived thinning hair. Participants take either a low or high dose daily, and researchers measure hair thickness and strength using scalp imaging. The goal is to see if the supplement can improve hair growth and reduce shedding.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Biotin, Collagen, Keratin, and Hyaluronic Acid dietary supplement
What this could lead to
If it works, this could point toward an effective over-the-counter supplement option for improving hair thickness and strength in people with temporary thinning hair.
What could go wrong
This is a small, early-stage trial with only 40 participants and no placebo group, so results may not be generalizable. The supplement is not a drug and effects may be modest or due to chance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jan 2026

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants must meet all of the following criteria: 1. Adults aged 21-50 years. 2. Generally healthy, as determined by medical history, physical exam, and available laboratory results from Visit 1 (Day -1/Day 0). 3. Self-perceived thinning hair associated with diet, stress, or hormonal influences. 4. Willingness to maintain the usual hair care routine, including shampoo frequency, and consistent haircut/color during the study. 5. Willingness to take the study supplement daily as instructed. 6. Willingness to avoid major changes in diet, medications, or exercise during the study and to notify the clinic of any changes. 7. Willingness to undergo all required assessments, including physical exam, vital signs, hematology, urine pregnancy test (if applicable), scalp exam, hair photography, and completion of the Hair Shedding Diary. 8. Fitzpatrick skin types I-IV. 9. Ability and willingness to provide written informed consent. Exclusion Criteria: Participants will be excluded if they meet any of the following: 1. Known allergy or intolerance to any component of the study supplement (e.g., biotin, keratin, collagen, fish/seafood, acerola). 2. Known allergy or sensitivity to hair care products specified for use in the study. 3. Pregnant, breastfeeding, or planning to become pregnant during the study period. 4. Significant stress event (e.g., death in family, miscarriage) within the past 6 months. 5. Participation in another clinical study concurrently. 6. Initiation of hormonal therapy within the past 6 months (stable use for at least 6 months allowed). 7. Current use of light therapy for hair loss. 8. Use of minoxidil or other hair growth medications within the last 3 months. 9. Current use of biotin, keratin, collagen, or similar supplements. 10. Use of prescription medications known to affect hair growth within the last 6 months. 11. Hair disorders other than self-perceived thinning hair (e.g., alopecia areata, scarring alopecia, androgenetic alopecia, telogen effluvium). 12. Uncontrolled chronic diseases (e.g., diabetes, hypertension, thyroid disorders). Stable, well-controlled conditions may be allowed at the investigator's discretion. 13. Active hepatitis, immune deficiency, human immunodeficiency virus (HIV) infection, or autoimmune disease. 14. Active dermatologic conditions that may interfere with assessments or increase risk (e.g., severe seborrheic dermatitis, psoriasis, advanced skin cancer).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hair thinning are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Limited Liability Company Treatment and Diagnostic Center ADONIS Plus

    Kyiv, Kyiv Oblast, 02002,, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.